Growing community of inventors

Arlington, MA, United States of America

Martin R Hodge

Average Co-Inventor Count = 1.50

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 26

Martin R HodgeLaurie H Glimcher (3 patents)Martin R HodgeDavid Yowe (3 patents)Martin R HodgeRachel E Meyers (2 patents)Martin R HodgeMark Williamson (2 patents)Martin R HodgeNadine Weich (1 patent)Martin R HodgeClare Lloyd (1 patent)Martin R HodgeMartin R Hodge (15 patents)Laurie H GlimcherLaurie H Glimcher (41 patents)David YoweDavid Yowe (4 patents)Rachel E MeyersRachel E Meyers (62 patents)Mark WilliamsonMark Williamson (31 patents)Nadine WeichNadine Weich (12 patents)Clare LloydClare Lloyd (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Millennium Pharmaceuticals Limited (11 from 850 patents)

2. Harvard College (3 from 2,971 patents)

3. Millenium Pharmaceuticals, Inc. (1 from 36 patents)


15 patents:

1. 7759085 - 14189, a novel human kinase and uses thereof

2. 7655432 - Kinases and uses thereof

3. 7425424 - Kinases and uses thereof

4. 7214374 - 12832, a novel human kinase-like molecule and uses thereof

5. 6858418 - Kinases and uses thereof

6. 6830914 - RGS-containing molecules and uses thereof

7. 6759221 - 14189, a novel human kinase and uses thereof

8. 6733990 - Nucleic acid encoding 15571, a GPCR-like molecule of the secretin-like family

9. 6656698 - 12832, a novel human kinase-like molecule and uses thereof

10. 6573365 - Antibodies for NF-AT interacting protein, NIP45

11. 6558903 - Kinases and uses thereof

12. 6410240 - RGS-containing molecules and uses thereof

13. 6274362 - RGS-containing molecules and uses thereof

14. 6090561 - NF-AT-interacting protein NIP45 and methods of use therefor

15. 5858711 - NF-AT-interacting protein NIP45 and methods of use therefor

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/7/2026
Loading…